LncRNA H19 rs4929984 Variant is Associated with Coronary Artery Disease Susceptibility in Han Chinese Female Population.
Jiao HuangMinhua LiJinhong LiBaoyun LiangZhaoxia ChenJialei YangXiaojing GuoSiyun HuangLian GuLi SuPublished in: Biochemical genetics (2021)
Long non-coding RNAs (lncRNAs) have been reported to play an important role in cardiovascular diseases. The present study aimed to investigate the levels of lncRNA H19 in patients with coronary artery disease (CAD) and the genetic association of lncRNA H19 rs217727 and rs4929984 polymorphisms with CAD susceptibility. We detected an upregulated expression of lncRNA H19 in the peripheral blood of CAD patients compared with healthy controls, and the area under the receiver operating characteristic curve of lncRNA H19 for CAD diagnosis was 0.918. In addition, rs4929984 was associated with the susceptibility of Han Chinese females to CAD, as shown in the additive and dominant models, and the significant association remained after adjusting for age and Bonferroni correction. The A allele carriers of rs4929984 were correlated with females' susceptibility to CAD compared with the C allele, and the A-G haplotype of rs4929984-rs217727 was associated with females' susceptibility to CAD. Furthermore, rs217727 and rs4929984 were associated with the levels of clinicopathological parameters of CAD cases. We suggest that lncRNA H19 has a potential to be a diagnostic biomarker for CAD; rs4929984 polymorphism is associated with females' susceptibility to CAD in the Han Chinese population, and lncRNA H19 variants may influence lipid metabolism, inflammation, and coagulation function of CAD patients.
Keyphrases
- coronary artery disease
- long non coding rna
- percutaneous coronary intervention
- cardiovascular events
- coronary artery bypass grafting
- poor prognosis
- end stage renal disease
- peripheral blood
- newly diagnosed
- cardiovascular disease
- long noncoding rna
- prognostic factors
- type diabetes
- peritoneal dialysis
- dna methylation
- copy number
- patient reported outcomes
- climate change
- binding protein
- transcatheter aortic valve replacement